Stay updated on India’s healthcare and pharma landscape. In this episode, we cover the flood of low-cost semaglutide generics after patent expiry, sharp price drops improving access for diabetes patients, rising concerns over misuse as a weight-loss drug, and…
From mass protests in the United States and the passing of Vijaypat Singhania to key insolvency rulings and the Vedanta Adani dispute here are todays top political, business, legal, and corporate sto… [+1723 chars]
